HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs.

Abstract
Aberrant expression of secreted proteinases and their specific inhibitors is believed to represent an important factor in the pathogenesis of invasion and metastases of malignant neoplasms. Our previous data indicated a link between elevated expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) and the clinical aggressiveness of malignant non-Hodgkin's lymphomas. Further studies are presented on eighteen cases of high grade, large cell immunoblastic lymphoma in which expression at the RNA level of TIMP-1 and the metalloproteinase, 92 kDa gelatinase, were analyzed. Factors that may influence production of 92 kDa gelatinase, such as necrosis, vascularity, proliferative activity, and extranodal extension, as well as clinical parameters, such as age and sex, stage, location, and survival were assessed. Statistical analysis showed that, although clinical stage was the most important predictor of survival, after controlling for age at diagnosis, levels of 92 kDa gelatinase transcripts added to the ability to predict survival.
AuthorsA E Kossakowska, S J Urbanski, S A Huchcroft, D R Edwards
JournalOncology research (Oncol Res) Vol. 4 Issue 6 Pg. 233-40 ( 1992) ISSN: 0965-0407 [Print] United States
PMID1421616 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glycoproteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Tissue Inhibitor of Metalloproteinases
  • Collagenases
  • Matrix Metalloproteinase 9
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Collagenases (analysis)
  • Female
  • Glycoproteins (analysis)
  • Humans
  • Lymphoma, Large-Cell, Immunoblastic (enzymology, mortality, pathology)
  • Male
  • Matrix Metalloproteinase 9
  • Middle Aged
  • Molecular Weight
  • Prognosis
  • RNA, Messenger (analysis)
  • RNA, Neoplasm (analysis)
  • Survival Analysis
  • Tissue Inhibitor of Metalloproteinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: